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Abstract
Objective: The aims were to explore if bulimic spectrum disorders (BSD)
patients, who also present comorbid compulsive buying (CB), could represent
a specific subtype considering its neuropsychological performance; to present a
descriptive analysis of different clinical features; and to explore how these
variables could influence treatment outcome. It was hypothesised that the
comorbid group will present worse neuropsychological performance that will
lead to a worse treatment outcome.
Method: The study has a longitudinal design. Women (N = 75) diagnosed
with BSD, BSD + CB and Healthy Controls (HC); completed an evaluation of:
cognitive flexibility, decision making, eating disorder (ED) symptomatology,
psychopathological state and personality traits.
Abbreviations: ANOVA, analysis of variance; BA, behavioural addiction; BMI, body mass index; BN, bulimia nervosa; BSD, bulimic spectrum
disorders; BSD + CB, bulimic spectrum disorder with comorbid compulsive buying; C, colour; CB, compulsive buying; CBT, cognitive behavioural
therapy; CFI, Bentler’s Comparative Fit Index; DSM‐5, Diagnostic and Statistical Manual of Mental Disorders 5; ED, eating disorder; EDI‐2, Eating
Disorder Inventory‐2; GSI, Global Severity Index; HC, healthy controls; ICD‐11, International Classification of Diseases 11; IGT, Iowa Gambling
Task; N, number; PSDI, Positive Symptom Distress Index; PST, Positive Symptoms Total; RMSEA, root mean square error of approximation; S,
shape; SCL‐90‐R, Symptom Checklist‐90 Items‐Revised; SD, standard deviation; SEM, structural equation model; SRMR, standardised root mean
square residuals; TCI‐R, Temperament and Character Inventory–Revised; TLI, Tuker–Lewis Index; WCST, Wisconsin Card Sorting Test.
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Results: BSD + CB was the group with the most severe clinical profile, worst
treatment outcome and higher neuropsychological impairment, than other
groups. Path‐analysis evidenced that deficits in decision making were associ-
ated with bad treatment outcome, while deficits in flexibility with the presence
of the comorbidity. Self‐directedness and novelty seeking were associated with
the neuropsychological performance and the comorbidity.
Conclusion: BSD + CB exhibit a worse clinical and neuropsychological profile
that seems to be related with the treatment outcome, which should be taken
into account for the establishment of specific treatment approaches.
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Highlights
� Bulimic spectrum disorders comorbid with compulsive buying present with
the most severe clinical profile and the worst treatment outcome.
� The comorbid group exhibit more neuropsychological deficits than the non‐
comorbid one and the healthy controls.
� Deficits in decision making were directly and positively associated with bad
treatment outcome, while deficits in flexibility with the comorbid presence
of the disorders.
� Personality traits were associated with the neuropsychological performance
and the comorbidity.
1 | INTRODUCTION
Impulsivity has been defined as a tendency to respond
with little forethought, often with disregard to the
negative consequences to the impulsive behaviour to the
individual or others (Moeller et al., 2001). It has
been related to psychopathological conditions, such as
eating disorders (EDs) or behavioural addictions
(BA) (Lee et al., 2019; Mallorquí‐Bagué et al., 2020;
Waxman, 2009).
ED subtypes that are associated with high impulsive
traits usually present with binge eating behaviours. Ac-
cording to the taxonomy of the Diagnostic and Statistical
Manual of Mental Disorders (DSM‐5; American Psychi-
atric Association, 2013), bulimia nervosa (BN) is char-
acterised by recurrent episodes of binge eating (eating
large amounts with loss of control) and compensatory
behaviours to prevent weight gain, which can include
self‐induced vomiting, inappropriate use of medicines,
fasting or extreme exercise, whereas binge eating disorder
(BED) is characterised by distressing, recurrent episodes
of binge eating, with fewer compensatory behaviours.
These binge‐related impulsive behaviours, BN and BED,
are known as binge spectrum disorders (BSD) (Treasure
et al., 2020). Likewise, BA have been defined referring to
persistent and maladaptive behaviours, in spite of the
negative later repercussions, implying loss of control,
craving, onset of tolerance and abstinence (Grant
et al., 2010). Therefore, impulsivity traits are also highly
related to BA (Lee et al., 2019).
BSD diagnosis have usually showed comorbidity with
BA (Fernández‐Aranda et al., 2006, 2008). The afore-
mentioned link between BSD, and BA has motivated
research into the presence of common core factors be-
tween them, including aspects of biological, neuro-
cognitive and psychological nature.
According to biological models, dopamine has been
associated with addictive processes and BSD. BED pa-
tients have shown greater density and higher binding
potential of the dopamine D2 receptor, both related with
enhanced dopamine signalling. This condition may pre-
dispose to reward hypersensitivity (Davis et al., 2012) and
changes in dopamine release, as predictors of binge
eating (Wang et al., 2011). The same dopamine receptors
(D2) have been found to be related with the control of
reward‐associated behaviours, as in substance use disor-
ders (Baik, 2013; Volkow & Li, 2005). Related with neu-
rocognition, patients diagnosed with BED have shown
impaired response inhibition and cognitive planning
(Grant & Chamberlain, 2020). In a similar way,
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individuals with BA perform disadvantageously on
decision‐making tasks (Bechara, 2003), as well as pre-
senting with a diminished performance on tests of inhi-
bition, cognitive flexibility and planning tasks (Ko
et al., 2010). Considering personality traits, in BN patients
with a lifetime comorbid BA the presence of high
impulsive tendencies, harm avoidance and novelty
seeking, as well lower self‐directedness, and lower
cooperativeness have been found (Álvarez‐Moya
et al., 2007; Del Pino‐Gutiérrez et al., 2017; Fischer &
Smith, 2008; Jiménez‐Murcia et al., 2013). Additionally,
in ED patients, the presence of a BA is associated with
greater severity of the eating symptomatology (Fernán-
dez‐Aranda et al., 2006, 2008; Jiménez‐Murcia
et al., 2015), greater general psychiatric morbidity and
psychopathology (Bulik et al., 2004; Fernández‐Aranda
et al., 2008; Mitchell et al., 2002) and poorer prognosis
than those without comorbid BA (Fernández‐Aranda
et al., 2006, 2008). All these findings suggest that at the
clinical level, BSD with comorbid BA could be a different
subtype.
Among the BA that are usually found in BSD, higher
rates of comorbidity have been found with compulsive
buying disorder (CB) (Faber et al., 1995; Fernández‐
Aranda et al., 2006, 2008; Jiménez‐Murcia et al., 2015;
Mitchell et al., 2002). Even though the specific aetiology
of CB is still unknown, it is a mental health condition
characterised by the persistent, excessive, impulsive and
uncontrollable purchase of products in spite of severe
psychological, social, occupational, financial conse-
quences which lead to distress (McElroy et al., 1994;
Müller et al., 2015).
As well, it follows the same addictive process as other
BA, as positive feelings are initially experienced while
shopping and buying, but over time the shopping epi-
sodes are used to alleviate negative moods (Christenson
et al., 1994; Kellett & Bolton, 2009), as well as a strategy
to cope with stress, and other materialism values such as
gaining social approval/recognition, and improve their
self‐image (Estévez et al., 2020; Lejoyeux & Wein-
stein, 2010; McQueen et al., 2014; Roberts et al., 2014).
Even though studies on CB prevalence report diverse
results (Harvanko et al., 2013; Mueller et al., 2011),
women tend to present this dysfunctional behaviour with
a higher percentage than men (Fernández‐Aranda
et al., 2019; Granero et al., 2016; Jiménez‐Murcia
et al., 2015; Maraz et al., 2016; Mueller et al., 2011).
Although it has not been included in the 5th edition of
the Diagnostic and Statistical Manual of Mental Disor-
ders (DSM‐5) (American Psychiatric Association, 2013),
several authors keep proposing that it should be included
in the 11th revision of the International Classification of
Diseases (ICD‐11) (Müller et al., 2019). In concordance
with the aforementioned, in the comorbid presence of CB
and BSD high impulsivity, novelty seeking and eating
symptomatology, as well as bad psychopathological state,
have been found (Fernández‐Aranda et al., 2019; Jimé-
nez‐Murcia et al., 2015).
The reinforcing effect of some impulsive behaviours,
such as gambling, buying, binge eating and purging,
support the hypothesis that these disorders are associated
with dysfunctions in the brain's reward system (Fineberg
et al., 2010; Probst & Van Eimeren, 2013). Consequently,
people with CB usually present altered activity in the
brain's reward system. When performing purchasing
decisions, they show higher activation in the striatum
than people without this disorder, specifically in the
nucleus accumbens (Raab et al., 2011). This may be
related to decreased activity in the ventromedial pre-
frontal cortex, which plays an important role in planning
and decision making processes (Hiser & Koenigs, 2018;
Wagar & Thagard, 2004). However, to the best of our
knowledge, no study has explored if patients with co-
morbid BSD + CB show worse neuropsychological
functioning than those BSD patients without the
comorbidity.
Therefore, the aim of the present study was to
explore if patients with comorbid BSD + CB, could
represent a specific subtype, considering its neuropsy-
chological performance. Additionally, to present a
descriptive analysis of clinical features of patients with
comorbid BSD + CB, and to explore how the mediation‐
interaction of these variables could influence treatment
outcome. Attending the previous results, BSD patients,
who are characterised by high impulsive traits, also
report poor neurocognitive performance. Then, this
impaired performance could be even worse in those
patients who also present poor impulse control in other
behaviours such as CB. Therefore, we hypothesised that
the comorbid group will present worse neuropsycho-
logical performance, more maladaptive personality traits,
higher ED symptomatology, worse psychopathological
state and worse treatment outcome, than the patients
without comorbidity.
The implications of the present study are that if a
subtype of the comorbid presence of BSD and CB is
identified, and is related with a bad treatment outcome,
proper treatment approaches could be offered to the pa-
tients considering the characterisation of the comorbid
subtype. This may be helpful considering that a progres-
sive significant impairment of overall individ-
ual functioning has been found in both, BSD (American
Psychiatric Association, 2013) and CB, in which patients
may present feelings of regret/remorse over purchases,
shame, guilt, legal and financial problems, and other
interpersonal difficulties (Thege et al., 2015).
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2 | MATERIALS AND METHODS
2.1 | Participants
Regarding the clinical groups, the participants consec-
utively referred for assessment and treatment at the
Unit of Eating Disorders of the Department of Psychi-
atry of the University Hospital of Bellvige in Barcelona.
From an initial sample of 97 BSD patients (51 with BN
and 46 with BED) that conducted neuropsychological
assessment, 25 patients presented CB (25.77%) life time,
being the ones that was selected for the present study.
For the same sample, 25 patients with only BSD, with
the same age range and similar education level, were
randomly selected. Following the same line, 25 healthy
controls from the same geographic area were matched
for age and education level, recruited via word‐of‐
mouth and advertisements. To be eligible for the
study, participants could not have a lifetime history of
an eating disorder and current obesity or any behav-
ioural addiction.
Therefore, the total sample comprised 75 women, 25
with BSD, 25 with BSD and comorbid CB and 25 healthy
controls. All participants from the clinical groups
included in the study were diagnosed according to the
Diagnostic and Statistical Manual of Mental Disorders,
Fifth Edition (DSM‐5) criteria (American Psychiatric
Association, 2013).
2.2 | Psychological assessment
Temperament and Character Inventory–Revised
(TCI‐R) (Cloninger, 1999) is a 240‐item questionnaire
with a five‐point Likert scale format. It measures four
temperaments (harm avoidance, novelty seeking,
reward dependence and persistence) and three char-
acter dimensions (self‐directedness, cooperativeness and
self‐transcendence). This questionnaire has been vali-
dated in a Spanish adult population (Gutiérrez‐Zotes
et al., 2004). The Cronbach's alpha for the different
scales in the current sample were into the good range,
from α = 0.80 (for novelty seeking) to α = 0.87 (for
harm avoidance).
Symptom Checklist‐90 Items‐Revised (SCL‐90‐R)
(Derogatis, 1994) is a 90‐item questionnaire used
for assessing self‐reported psychological distress and
psychopathology. It evaluates nine primary symptom
dimensions: somatisation, obsessive‐compulsive, inter-
personal sensitivity, depression, anxiety, hostility,
phobic anxiety, paranoid ideation and psychoticism, as
well as three global indices: Global Severity Index (GSI),
Positive Symptom Total (PST), and Positive Symptom
Distress Index (PSDI). This instrument has been vali-
dated in a Spanish population (Derogatis, 2002). The
internal consistency for the global index in our sample
was α = 0.97.
Eating Disorder Inventory‐2 (EDI‐2) is a 91‐item
multidimensional self‐report questionnaire that assesses
psychological and behavioural characteristics relevant to
eating disorders. The questionnaire consists of 11 sub-
scales, answered on a six‐point Likert scale: drive for
thinness, body dissatisfaction, bulimia, ineffectiveness,
perfectionism, interpersonal distrust, interoceptive
awareness, maturity fears, asceticism, impulse regulation
and social insecurity. This instrument have been vali-
dated in a Spanish population (Garner, 1998). The in-
ternal consistency of the EDI‐2 total score in our sample
was α = 0.93.
Compulsive buying assessment. We conducted a
face to face semi‐structured interview exploring buying
attitudes, associated feelings, underlying thoughts and
the extent of preoccupation with buying and shopping,
as recommended (Müller et al., 2015). Diagnostic
criteria were determined for CB in accordance with
the guidelines set by McElroy et al. (1994). These
criteria have received considerable acceptance in the
research community, even though their validity and
reliability have not yet been determined (Tavares
et al., 2008).
Other measures. Additional information was
collected through a semi‐structured interview with the
clinicians. This interview included sex, age and edu-
cation level, as well as information regarding the
presence or absence of impulsive behaviours (including
alcohol abuse, drugs abuse, binge episodes, theft and
kleptomania).
2.3 | Neuropsychological measures
Executive function performance was evaluated consid-
ering two subdomains: cognitive flexibility and decision‐
making.
The Wisconsin Card Sorting Test (WCST) (Hea-
ton & PAR Staff, 2003) is a computerised set‐shifting task
for assessing cognitive flexibility. It includes 128 cards
that vary according to three attributes: number (N),
colour (C) and shape (S). The participant has to pile the
cards beneath four reference cards that also vary along
these same dimensions, and in order to succeed, they
have to settle upon a predetermined sorting rule. The
only feedback given to the participant is the word ‘right’
or ‘wrong’ after each sorting. Initially, C is the correct
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sorting category, and positive feedback is given only if the
card is placed in the pile with the same colour. After 10
consecutive correct sorts, the rule changes. Thus, the
positive feedback is only given when the sorting matches
the new category. By trial and error, the participant must
learn to change the sorting categories according to the
given feedback. There are up to six attempts to derive a
rule, providing rule shifts in the following category
sequence: C‐S‐N‐C‐S‐N. Participants are not informed of
the correct sorting principle and that the sorting principle
shifts during the test. The test is completed when all 128
cards are sorted or after the six full categories are
completed. The number of completed categories, the
percentage of perseverative errors (i.e., failures to change
sorting strategy after negative feedback) and the per-
centage of non‐perseverative errors are recorded. Other
measures include total trials, total errors, conceptual,
perseverative responses and trials to complete first
category.
The Iowa Gambling Task (IGT) (Bechara
et al., 1994) is a computerised task to evaluate decision‐
making, which has also been proposed as a measure of
choice impulsivity (Eisinger et al., 2016). It involves a
total of 100 turns distributed across four decks of cards
(A, B, C and D), and each time the participant selects a
deck, a specified amount of play money is awarded. The
interspersed rewards among these decks are probabilistic
punishments (monetary losses with different amounts).
Participants are instructed that the final aim of the task is
to win as much money as possible and to avoid losing as
much money as possible. Moreover, they may choose
cards from any deck, and switch decks at any time. This
test is scored by subtracting the number of cards selected
from decks A and B from the number of cards selected
from decks C and D. Decks A and B are not advanta-
geous as the final loss is higher than the final gain;
however, decks C and D are advantageous since the
punishments are smaller. Higher scores indicate better
performance on the task.
The IGT is divided into five blocks. The first blocks
are supposed to assess the decision‐making process under
ambiguity conditions while the last blocks (after the 40th
selection) are used to assess the decision‐making capa-
bilities under risk conditions due to the rules have been
figured out at this point (Brand et al., 2006).
Several indices were used to analyse performance in
the IGT: the total score for each block of 20 cards (the
first block is thought through a measure of decision
making under ambiguity); the IGT total score, which
would be the difference among the total number of cards
selected from the Decks A and B (disadvantageous ones)
and those selected from the Decks C and D (advanta-
geous ones); the IGT learning score, that is, the difference
among the net score in the last two blocks and the net
score in the first two; the IGT risk score, that is, the score
of the last two blocks added together (a measure of de-
cision making under risk or certainty) (Giannunzio
et al., 2018).
2.4 | Treatment outcome
Patients with BSD received 16 weekly outpatient group
therapies based on CBT, previously described (Fernán-
dez‐Aranda & Turón‐Gil, 1998), by an experienced
psychologist. Patients were re‐evaluated at discharge and
categorised into three categories: ‘full remission’, ‘partial
remission’ and ‘non‐remission’. Voluntary treatment
discontinuation was categorised as ‘dropout’ (i.e., not
attending treatment for three consecutive sessions was
considered dropout). Following the guidelines of treat-
ment outcome according to DSM‐5 criteria (American
Psychiatric Association, 2013), the working definition of
a ‘full remission’ outcome was a total absence of
symptoms meeting diagnostic criteria for at least four
consecutive weeks, ‘partial remission’ was defined as
substantial symptomatic improvement but the continued
presence of residual symptoms for at least four consec-
utive weeks, finally, patients who presented ‘non‐
remission’ and dropout were labelled as poor outcome,
these categories were previously used to assess treat-
ment outcome in other published studies (Agüera
et al., 2013, 2015; Lucas et al., 2021; Sauchelli
et al., 2016; Steward et al., 2016). These categories were
based on the consensus judgement of the senior clinical
staff who considered all aspects of the patient's treat-
ment outcome, such as normalisation of nutritional di-
etary patterns, frequency of binge episodes and
compensatory behaviours (such as self‐induced vomiting
or laxative and diuretics misuse), weight restoration,
improvement in attitudes regarding weight and shape
and ED cognitions.
2.5 | Procedure
All participants in our sample voluntarily sought treat-
ment for ED and were diagnosed according to the DSM‐5
criteria (American Psychiatric Association, 2013) by
clinical psychologists and psychiatrists with more than 15
years of experience in the field. They conducted two face‐
to‐face clinical interviews, before and after a psycho-
metric evaluation. The neuropsychological tests were
selected to cover various aspects of executive functions
and were administered by a trained psychologist in a
single session, prior to treatment onset. The patients
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included in this study did not receive any kind of
compensation for their participation.
The present study was approved by the appropriate
research committee, according to the Declaration of
Helsinki. Written and signed informed consent was ob-
tained from all participants.
2.6 | Statistical analysis
Statistical analysis was carried out with Stata16 for win-
dows (Stata‐Corp, 2019). Comparisons between the
groups were based on chi‐square tests (χ2) for categorical
variables and analysis of variance (ANOVA) for quanti-
tative measures. Effect size for mean differences was
estimated through the standardised Cohen's‐d coefficient
(it was considered null for |d|<0.20, low‐poor for |d|
>0.20, moderate‐medium for |d|>0.50 and large‐high for
|d|>0.80). Effect size for proportion differences was ob-
tained through Cohen's‐h coefficient, based on the dif-
ference of the arcsine transformation of the rates
obtained in the groups. The rule of thumb for the inter-
pretation of the resulting coefficient is the same than
Cohen's‐d (cut of 0.20, 0.50 and 0.80 are interpreted as
small effect, mild‐medium effect size and high‐large ef-
fect size, respectively) (Cohen, 1988).
In this work, two categorical‐binary measures were
calculated for measuring the presence of deficit in the
decision making and flexibility areas. These two classifi-
cations were based in the normative data published in the
manuals of each test. Percentile 16th was selected as the
threshold (this cut‐off is usually considered for identi-
fying the high risk of impairing performance). Impairing
decision making was assigned to participants with IGT
total score under the percentile 16th, while impairing
flexibility was assigned to participants with scores under
the percentile 16th in any of the WCST scales persever-
ative errors, non‐perseverative errors and number of
categories completed.
Path analysis carried out through structural equation
models (SEM) estimate the role/s, magnitude/s and sig-
nificance of the associations between personality mea-
sures, deficit in the neuropsychological performance,
diagnostic group and treatment outcome, obtained for the
clinical subsamples (BSD and BSD + CB groups). Path
analysis constitutes a multivariate procedure for testing
direct, indirect and total effects (including mediational
links). The model was adjusted with the maximum‐
likelihood estimation method of parameter estimation
and goodness‐of‐fit was measured with χ2 test, root mean
square error of approximation (RMSEA), Bentler's
Comparative Fit Index (CFI), Tuker–Lewis Index (TLI)
and standardised root mean square residuals (SRMR)
(adequate fitting was considered for non‐significant
result in the χ2 test, RMSEA < 0.08, CFI > 0.95,
TLI > 0.95 and SRMR < 0.08 (Barrett, 2007).
In this study, increase in the Type I error due to the
multiple significance tests was controlled through the
Finner‐method (Finner & Roters, 2001), a Familywise
error rate stepwise procedure which has proved more
powerful than the classical Bonferroni correction.
3 | RESULTS
3.1 | Characteristics of the sample
The top block of Table 1 shows the sociodemographic
descriptive data for the sample. The control group mainly
included single subjects, with secondary or higher edu-
cation and in an active work situation (the mean age of
this group was 31.2 years old, SD = 10.2). BSD patients
were mainly single or married, with primary studies
levels and employed (mean age was 35.0, SD = 10.3).
BSD + CB also grouped mainly single patients, with
primary studies levels and unemployed (mean age was
34.2, SD = 10.6).
Regarding the clinical profiles (bottom part of
Table 2), as expected the control group showed better
psychopathological status (lower means in the ED
severity and psychological distress) and less harm
avoidance and higher self‐directedness than the two
clinical groups. BSD + CB was the group with the most
impaired clinical profile (higher means in the ED severity
and the psychological distress, as well as higher novelty
seeking, higher harm avoidance and less self‐directed-
ness). BSD + CB also registered later age of onset of the
eating related problems.
3.2 | Comparison of the
neuropsychological measures
Table 2 contains the comparison between the groups
for the neuropsychological measures analysed in the
study. Regarding the IGT task, the BSD + CB condition
registered the worse profile with the lowest scores in
the Learning and the Risk constructs. Regarding the
WCST, no differences between the groups were found.
For the binary scores identifying the high risk of
deficit (in the decision making and flexibility areas) the
worse performance was registered for BSD + CB, fol-
lowed by BSD, while HC registered the lowest risks of
deficit.
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Figure 1 shows the performance learning curve in
the IGT obtained in each group (mean IGT scores on
the five consecutive blocks of the card draws). Dash
lines represent the trend line with the best fit within
each diagnostic condition (linear trend for HC and BSD,
and polynomial cubic trend for BSD + CB). As ex-
pected, the best performance learning was achieved by
HC controls, followed by BSD patients. BSD + CB
group did not reach adequate performance in the
learning task.
3.3 | Therapy outcome
Table 3 contains the distribution of the therapy outcome
in the clinical groups, as well as the results of the











n % n % n % p |h| p |h| p |h|
Marital status
Single 20 80.0% 12 48.0% 17 68.0% 0.045* 0.68a 0.591 0.28 0.167 0.41
Married 3 12.0% 10 40.0% 4 16.0% 0.66a 0.12 0.55a
Divorced/separated 2 8.0% 3 12.0% 4 16.0% 0.13 0.25 0.12
Education
Primary 4 16.0% 12 48.0% 13 52.0% 0.046* 0.71a 0.024* 0.79a 0.927 0.08
Secondary 12 48.0% 8 32.0% 8 32.0% 0.33 0.33 0.00
University 9 36.0% 5 20.0% 4 16.0% 0.36 0.51a 0.10
Employment
Unemployed 3 12.0% 11 44.0% 15 60.0% 0.012* 0.74a 0.001* 1.06b 0.258 0.32
Employed/student 22 88.0% 14 56.0% 10 40.0%
Mean SD Mean SD Mean SD p |d| p |d| p |d|
Age (years) 31.20 10.23 34.96 10.31 34.20 10.56 0.204 0.37 0.310 0.29 0.796 0.07
Onset of ED (years) – – 22.00 8.86 32.20 21.43 – – – – 0.033* 0.62a
Duration of ED (years) – – 13.16 8.55 11.44 8.80 – – – – 0.487 0.20
BMI (kg/m2) – – 36.22 12.93 32.35 8.95 – – – – 0.35
EDI‐2 total 33.16 27.65 106.80 39.39 131.88 26.97 0.001* 2.16b 0.001* 3.61b 0.007* 0.74a
SCL‐90R GSI 0.63 0.41 1.67 0.79 2.21 0.61 0.001* 1.67b 0.001* 3.05b 0.003* 0.77a
TCI‐R novelty seeking 103.48 9.82 99.88 14.62 112.48 15.60 0.352 0.29 0.022* 0.69a 0.002* 0.83b
TCI‐R harm avoidance 91.44 15.83 121.52 17.34 131.88 14.96 0.001* 1.81b 0.001* 2.63b 0.026* 0.64a
TCI‐R reward dep. 108.60 10.36 104.60 15.92 103.96 18.62 0.360 0.30 0.289 0.31 0.883 0.04
TCI‐R persistence 114.64 23.55 100.56 15.28 103.44 20.79 0.016* 0.71a 0.053 0.46 0.615 0.16
TCI‐R self‐directedness 143.72 17.61 119.12 20.24 99.80 16.25 0.001* 1.30b 0.001* 2.59b 0.001* 1.05b
TCI‐R cooperativeness 135.68 26.63 139.76 15.62 130.76 19.44 0.496 0.19 0.412 0.21 0.135 0.51a
TCI‐R self‐transcendence 67.80 22.71 63.04 13.49 67.04 14.71 0.338 0.25 0.878 0.04 0.421 0.28
Abbreviations: BMI, body mass index; BSD, bulimic spectrum disorder; BSD + CB, bulimic spectrum disorder with compulsive buying; HC, healthy control;
SD, standard deviation.
aBold: effect size into the medium range (50 ≤ |d| < 0.80 or 50 ≤ |h| < 0.80).
bBold: effect size into the large range (|d| ≥ 0.80 or |h| ≥ 0.80).
*Bold: significant comparison.
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Mean SD Mean SD Mean SD p |d| p |d| p |d|
IGT: Block1 −1.20 7.14 −3.12 3.92 −1.53 4.85 0.219 0.33 0.832 0.05 0.308 0.36
IGT: Block2 0.40 7.90 −1.76 5.49 1.29 3.41 0.199 0.32 0.594 0.15 0.071 0.67a
IGT: Block3 1.84 9.07 −1.44 3.94 −0.35 6.12 0.088 0.47 0.252 0.28 0.568 0.21
IGT: Block4 1.68 9.99 −0.40 5.60 −2.00 7.12 0.348 0.26 0.099 0.42 0.470 0.25
IGT: Block5 2.08 10.34 0.08 5.55 −3.06 7.07 0.374 0.24 0.025* 0.58a 0.165 0.52a
IGT: total 4.80 30.84 −6.64 15.28 −5.65 19.39 0.080 0.47 0.110 0.41 0.878 0.06
IGT: learning 4.56 16.56 4.56 8.71 −4.82 9.87 0.999 0.00 0.008* 0.69a 0.008* 1.01b
IGT: risk 3.76 16.51 −0.32 8.77 −5.06 10.05 0.243 0.31 0.013* 0.65a 0.176 0.50a
WCST: trials 94.84 20.72 96.53 17.78 91.56 12.71 0.732 0.09 0.507 0.19 0.315 0.32
WCST: errors 26.36 24.30 28.47 20.61 25.78 14.43 0.713 0.09 0.919 0.03 0.639 0.15
WCST: conceptual 62.36 17.64 60.06 15.96 59.22 8.12 0.577 0.14 0.447 0.23 0.839 0.07
WCST: completed categ. 5.12 1.94 5.06 1.64 5.11 1.06 0.893 0.03 0.983 0.01 0.910 0.04
WCST: Persev.responses 14.56 13.96 14.65 10.74 15.50 12.21 0.980 0.01 0.789 0.07 0.808 0.07
WCST: persev.errors 13.28 12.21 13.53 9.06 14.33 9.76 0.933 0.02 0.723 0.10 0.787 0.09
WCST: non‐persev. Errors 13.08 12.96 14.94 14.29 11.44 5.55 0.572 0.14 0.619 0.16 0.289 0.32
WCST: trials‐first‐category 25.60 34.99 27.76 31.41 20.33 10.03 0.784 0.07 0.504 0.20 0.347 0.32
n % n % n % p |h| p |h| p |h|
Deficit: decision making 10 40.0% 14 56.0% 17 68.0% 0.258 0.32 0.047* 0.57a 0.382 0.25
Deficit: flexibility 6 24.0% 12 48.0% 18 72.0% 0.077 0.51a 0.001* 1.00b 0.083 0.50a
Abbreviations: BSD, bulimic spectrum disorder; BSD + CB, bulimic spectrum disorder with compulsive buying; HC, healthy control; SD, standard deviation.
aBold: effect size into the medium range (50 ≤ |d| < 0.80 or 50 ≤ |h| < 0.80).
bBold: effect size into the large range (|d| ≥ 0.80 or |h| ≥ 0.80).
*Bold: significant comparison.
F I GURE 1 Performance learning curve in the IGT. BSD‐CB,
bulimic spectrum disorder without compulsive buying (n = 25);
BSD + CB, bulimic spectrum disorder with compulsive buying
(n = 25); HC, healthy control (n = 25)
TABLE 3 Therapy outcome and deficit in the
neuropsychological performance in the study
BSD; (n = 25)
BSD + CB;
(n = 23)
n % n % p |h|
Treatment
outcome
Dropout 3 12.0% 10 43.5% 0.025* 0.73a
Non‐
remission
4 16.0% 1 4.3% 0.40
Partial‐
remission
5 20.0% 7 30.4% 0.24
Full‐
remission
13 52.0% 5 21.7% 0.64a
Abbreviations: BSD, bulimic spectrum disorder; BSD + CB, bulimic
spectrum disorder with compulsive buying.
aBold: effect size into the medium range (50 ≤ |d| < 0.80 or 50 ≤ |h| < 0.80).
*Bold: significant comparison.
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statistical comparison. Differences between the groups
were obtained, being the comorbid BSD + CB associated
to worse efficiency.
3.4 | Path analysis
Figure 2 includes the path diagram with the standardised
coefficients obtained in the SEM. Continuous line
represent significant coefficients (p ≤ 0.05) and dash‐lines
non‐significant coefficients. Adequate goodness‐of‐fit
was obtained for the model: χ2 = 3.82 (p = 0.80),
RMSEA = 0.002, CFI = 0.998, TLI = 0.999 and
SRMR = 0.047. Lower scores in the self‐directedness
personality traits increased the risk of deficit in the de-
cision making area and the presence of the comorbid
condition BSD + CB. The concurrent presence of both
disorders was also directly associated with higher scores
in the novelty seeking personality trait and the presence
of deficit in the flexibility cognitive area. Bad treatment
outcome (considered in the study as dropout or non‐
remission) was directly related with the presence of
deficit in decision making, and this neuropsychological
score also mediated within the relationship between self‐
directedness and bad outcome (lower scores in the per-
sonality trait increased the risk of deficits in decision
making, which predicted higher risk of bad therapy
outcome).
4 | DISCUSSION
The present study compared the neuropsychological
performance and psychological profiles of patients with
BSD + CB comorbidity, BSD patients and HC partici-
pants. The objectives were to assess if BSD + CB co-
morbidity could be a specific subtype according to their
neuropsychological functioning, present a descriptive
analysis of different clinical features and to explore how
the mediation‐interaction of these variables could influ-
ence treatment outcome.
Regarding our first objective, we observed that pa-
tients with BSD + CB comorbidity presented poorer
learning performance in the IGT than the patients
without comorbidity and the HC group. Both BSD and
HC groups showed a tendency to increase their selec-
tions from the advantageous decks with respect to the
initial blocks. On the contrary, BSD + CB group showed
the inverse trend, as they selected more cards from the
disadvantageous decks as the task progressed. The initial
blocks of the IGT represent a context of uncertainty,
where the results cannot be predicted, and the decisions
are made under ambiguity, whereas the last trials of the
task represent decisions made under risk (Giannunzio
et al., 2018). Therefore, the learning performance re-
quires the participant to learn from previous experience
in order to achieve better results. Also, the BSD + CB
group presented with a higher percentage of impaired
cognitive flexibility than the HC group. Our findings
support the hypothesis that the BSD + CB comorbidity is
associated with a poorer performance in a neuropsy-
chological task related with decision making and cogni-
tive flexibility.
The results agree with previous research that pointed
towards an impaired executive planning in patients with
binge‐eating behaviours (Grant & Chamberlain, 2020),
and also with those that indicated a poorer performance
in decision making and cognitive flexibility of patients
diagnosed with a BA (Bechara, 2003; Ko et al., 2010).
These neurocognitive variables may influence in part the
tendency toward the comorbidity. However, to the best of
our knowledge, this is the first approximation that con-
firms this neurocognitive profile in BSD with comorbid
CB patients.
F I GURE 2 Path‐diagram with the standardised coefficients. Continuous line: significant coefficient. Dash‐line: non‐significant
coefficient. Sample: clinical conditions (BSD and BSD + CB groups, n = 48). BSD, bulimic spectrum disorder; BSD + CB, bulimic spectrum
disorder with compulsive buying
MUNGUÍA ET AL. - 9
The second aim of this study was to present a
descriptive clinical characterisation of BSD + CB popu-
lation. The comorbid group presented with a more severe
profile than the patients with only BSD, considering
higher general psychopathology and severity of the ED
symptomatology; as well as predominant personality
traits usually associated with more dysfunctional behav-
iour, called higher novelty seeking and harm avoidance
and lower self‐directedness (Álvarez‐Moya et al., 2007;
Del Pino‐Gutiérrez et al., 2017; Jiménez‐Murcia
et al., 2013). According to the literature, a comorbid BA
in ED patients has been already associated to these re-
sults (Fernández‐Aranda et al., 2006, 2008; Jiménez‐
Murcia et al., 2015), which also seems to influence a poor
treatment response (Fernández‐Aranda et al., 2006,
2008), as was found in the present study by the comorbid
group whom presented more dropouts and less full‐
remission indices than the non‐comorbid one.
In relation to the aim of identifying if our target
population (BSD + CB) could be a different subtype, we
hypothesised that the neuropsychological performance
would be determinant in this respect. However, even if
this group present a worse performance in the neuro-
psychological tasks than the no comorbid one, the per-
sonality traits were the variables that had a mediation
and predictive role to present the comorbidity. Novelty
seeking was positively associated to present with the co-
morbidity, while self‐directedness was negatively associ-
ated. Both variables may be related with the impulsive
behaviours found in BSD and other BA (Álvarez‐Moya
et al., 2007; Del Pino‐Gutiérrez et al., 2017; Jiménez‐
Murcia et al., 2013) including CB (Fernández‐Aranda
et al., 2019; Jiménez‐Murcia et al., 2015). Interestingly,
only a low self‐directedness was significantly associated
with more deficits in decision making, and this low
neuropsychological performance mediated the relation-
ship between self‐directedness and bad outcome. Self‐
directedness indicates the ability to regulate and adapt
behaviour to the demands of a situation in order to
achieve personally chosen goals and values (Clo-
ninger, 1999), which, according our results, influences
the decision making process, and, as has been mentioned
in the literature, it is related with difficulties in following
therapy goals and achieving a good treatment outcome in
BSD and other BA (Fernández‐Aranda et al., 2021; Gra-
nero et al., 2020; Wagner et al., 2015). Also, the path‐
analysis showed that deficits in cognitive flexibility
were positively associated with the presence of the co-
morbidity. People with BSD + CB seem to act impulsively
despite its negative consequences, and they also show less
cognitive flexibility that could relate to the repetition and
maintenance of their unadjusted behaviours (Tchanturia
et al., 2012).
Therefore, even the executive functions could be
compromised in the comorbid group, it is a higher
impulsivity which seems to have an important role in the
characterisation of the BSD + CB profile, and could
explain the co‐occurrence of both disorders, as happens
in other BA comorbid to ED (Jiménez‐Murcia et al., 2013;
Von Ranson et al., 2013). These results may be taken into
account in considering an adequate treatment approach,
in order to offer a precise therapy to those patients that
present with this comorbidity. Considering the charac-
teristics of the comorbid group, therapies that improve
impulsive response, motivation and adherence to treat-
ment, as well as cognitive process may be helpful.
Mindfulness has shown positive results improving im-
pulse behaviours motivated by planning capacity deficits
(Korponay et al., 2019), as well as in the reduction of
compulsive eating behaviours (Radin et al., 2019). Serious
games may be another valuable tool for this comorbid
group due to the fact that it may help to improve the
motivation, help to develop positive relationships be-
tween patients and therapists, in this way dismissing the
dropout rates and reinforcing the adherence to treatment
(Tárrega et al., 2015).
4.1 | Limitations and future directions
The following limitations of this study need to be
considered. Aspects such as: the sample size, the inclu-
sion of only female, adult participants and from a specific
geographic area, limits the generalisation of the results.
Future studies should aim to use larger, more balanced
samples in order to overcome this drawback. It is also
important to consider that the present study only
explored neuropsychological performance in patients
with comorbid BSD and CB, future studies focusing on
other behavioural addictions, rather than only CB, could
be important in order to define a possible subtype of BSD
and behavioural addictions. As well, other cognitive
process, such as memory and attention, will be of interest
to be explored in this population.
5 | CONCLUSIONS
According to our results, people with this high impulsive
profile would also present more deficits in decision
making and cognitive flexibility as well as worse treat-
ment outcome. These results could indicate that the high
impulsive traits and subsequent impaired neuropsycho-
logical performance are features that directly influence
the presence of the comorbid BSD + CB, as well as relate
to poor treatment outcomes of the people who present
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this comorbidity. This study may represent a first explo-
ration of the neurocognitive profile in BSD with comor-
bid CB patients, and it could be possible to hypothesise
that the comorbidity may be a specific subtype of BSD,
but further research should be performed in order to be
able to establish it.
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